DSwiss, Inc.(DQWS.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
DSwiss, Inc.
DQWS.US
DSwiss, Inc., a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including beverages to assist in weight management, anti-aging creams, and products designed to enhance the health system in body. The company also provides private label manufacturing services for nutraceutical and skincare/personal care ODM/OEM products; pet wellness supplements; and pet-care products, as well as medical consumable supplies. Further, it offers OEM/ODM/OBM services; and biotechnology research channel services.
540.50 B
DQWS.USMarket value -Rank by Market Cap -/-

Financial Score

27/01/2026 Update
C
Personal Care ProductsIndustry
Industry Ranking37/55
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-24.28%E
    • Profit Margin-1.20%D
    • Gross Margin13.26%D
  • Growth ScoreB
    • Revenue YoY39.89%A
    • Net Profit YoY-158.75%E
    • Total Assets YoY-1.99%D
    • Net Assets YoY-25.18%E
  • Cash ScoreC
    • Cash Flow Margin-8302.11%E
    • OCF YoY39.89%A
  • Operating ScoreA
    • Turnover4.33A
  • Debt ScoreE
    • Gearing Ratio81.44%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    New Drug Administration Implementation Regulations Released: Allowing Innovative Drugs to be Produced in Segments, Accelerating the Market Launch of Good Medicines

    The State Council has announced the newly revised "Regulations for the Implementation of the Drug Administration Law," which will take effect on May 15, 2026. This is the first comprehensive revision of the regulations in over twenty years. The key points of the revision include: improving the drug registration system, establishing exclusive market periods for pediatric drugs and drugs for rare diseases for the first time (up to 2 years and 7 years respectively), clarifying four new drug expedited approval pathways; strengthening the responsibilities of online drug trading platforms and regulating online drug sales; allowing segmented commissioning of innovative drug production to optimize the industrial supply chain; and shifting the regulatory focus from enterprises to drug marketing authorization holders, enhancing lifecycle supervision

    Wallstreetcn·
    SZ
    159859
    -1.70%
    Wallstreetcn·
    SZ
    159859
    -1.70%

    In "Major Banks," China International Capital Corporation (CICC) states that the development of commercial health insurance in mainland China is expected to usher in a new era, focusing on four key areas

    CICC released a report indicating that the development of commercial health insurance in mainland China is expected to usher in a new era, focusing on four major areas. Insurance stocks performed strongly today, with China Life up 5.5%, Ping An up 2.5%, CPIC up 2.8%, and AIA up 3.9%. The report emphasizes that the policy combination will break through the bottlenecks in health insurance development and promote the industry towards positive feedback. It is recommended to pay attention to investment opportunities in internet platforms, large insurance groups, corporate group insurance, and health management

    AASTOCKS·
    SH
    601601
    +1.98%
    HK
    02601
    +2.67%
    HK
    01299
    +4.09%
    AASTOCKS·
    SH
    601601
    +1.98%
    HK
    02601
    +2.67%
    HK
    01299
    +4.09%

    Ma Shiheng: The settlement of hundreds of companies in Hong Kong is expected to attract USD 8 billion in investment and create 22,000 high-end jobs

    Chairman of the Hong Kong Trade Development Council, Peter Lam, stated at the AFF "Global Industry Summit" that current technologies such as artificial intelligence and biotechnology are reshaping the world and becoming the engines of future growth. He emphasized that financial services can enhance investment efficiency and support technological breakthroughs and sustainable development. Peter Lam mentioned that over 100 companies have established or expanded their businesses in Hong Kong, expected to bring in USD 8 billion in investments and create 22,000 high-end jobs

    AASTOCKS·
    HK
    00HSI
    +1.35%
    AASTOCKS·
    HK
    00HSI
    +1.35%

    National Bureau of Statistics: Last year, profits in the intelligent unmanned aerial vehicle manufacturing industry increased by 102% year-on-year

    According to data from the National Bureau of Statistics, the profit of the intelligent unmanned aerial vehicle manufacturing industry is expected to grow by 102% year-on-year in 2025, while the profit of the intelligent vehicle-mounted equipment manufacturing industry is expected to grow by 88.8%. The overall profit of the high-tech manufacturing industry is expected to grow by 13.3%, and the profit of the equipment manufacturing industry is expected to grow by 7.7%, significantly contributing to the profit growth of industrial enterprises. Despite the positive trends in the industrial economy, changes in the external environment pose challenges, and some enterprises still face difficulties. In the future, it is necessary to promote the integration of technology and industrial innovation and optimize the industrial structure

    AASTOCKS·
    AASTOCKS·

    Paul Chan: Hong Kong leverages its "Northern Metropolis" and financial advantages to create international corporate innovation and technology partnerships

    The Financial Secretary Paul Chan stated that Hong Kong is leveraging the trends of artificial intelligence and green transformation to promote the development of innovative technology, attracting international companies to settle, which is expected to bring in HKD 60 billion in investment and create 22,000 jobs. He emphasized that Hong Kong's status as a financial center will provide comprehensive funding support for enterprises and expand industrial space through the development of the "Northern Metropolis," promoting high-quality development and technological self-reliance

    AASTOCKS·
    AASTOCKS·
    © 2026 Longbridge｜Disclaimer